Santarus, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
- Biotechnology
Other Names/Subsidiaries
- Covella Pharmaceuticals, Inc.
Latest on Santarus, Inc.
The settlement of patent litigation over Bausch Health Companies Inc. 's diabetes treatment Glumetza (extended-release metformin) involves two controversial issues: drug price increases and generic p
The last two years have been transformational for the Leiden-based specialty company Pharming Group NV . In 2016, it had effectively lost control of the commercialization of its intravenous hereditar
Pharming Group NV has seen its first quarterly net profit in 2018 driven by sales of Ruconest – its own drug to which the company bought back the rights in 2016. In Q1 2018, Pharming saw a net prof
Pharming NV has the opportunity to achieve profitability in 2017, three years sooner than expected by reacquiring the rights to commercialize its hereditary angioedema (HAE) treatment in North Ameri